Genomic landscape of acquired resistance to targeted therapies in patients with solid tumors: A study from the National Center for Precision Medicine (PRISM)

被引：0
|
作者：
Bayle, Arnaud
Belcaid, Laila
Cousin, Sophie
Palmieri, Lola-Jade
Spalato, Mariella
Aldea, Mihaela
Vasseur, Damien
Alame, Melissa
Soubeyran, Isabelle
Nicotra, Claudio
Ngocamus, Maud
Ponce, Santiago
Loriot, Yohann
Besse, Benjamin
Lacroix, Ludovic
Rouleau, Etienne
Oxnard, Geoffrey R.
Barlesi, Fabrice
Andre, Fabrice
Italiano, Antoine
机构：
[1] Gustave Roussy Canc Ctr, Villejuif, France
[2] Rigshospitalet, Copenhagen, Denmark
[3] Inst Bergonie, Early Phase Clin Trials Unit & Thorac Unit, Bordeaux, France
[4] Inst Bergonie, Bordeaux, France
[5] Gustave Roussy, Dept Canc Med, Villejuif, France
[6] Gustave Roussy, Villejuif, France
[7] Inst Bergonie, Dept Biopathol, Mol Pathol Unit, Bordeaux, France
[8] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[9] Gustave Roussy, DITEP Drug Dev Dept, Villejuif, France
[10] Univ Paris Saclay, Gustave Roussy, DITEP, Villejuif, France
[11] Gustave Roussy, Dept Pathol & Med Biol, Canc Genet Lab, Villejuif, France
[12] Fdn Med, Cambridge, MA USA
[13] Univ Paris Sud, Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3016
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center
    Hussain, Taimoor
    Alaiya, Ayodele
    Dasouki, Majed
    Alzahrani, Hazzaa
    Al-Sabbagh, Afnan
    Al Ammari, Raghad
    Ghabashi, Emad
    Demirkaya, Abdullah Faruk
    Alawwami, Moheeb
    Chaudhri, Naeem A.
    Alsharif, Fahad Z.
    Rasheed, Walid
    Hanbali, Amr Suleiman
    Shaheen, Marwan
    Al Fraih, Feras
    Elfakih, Riad
    Hashmi, Shahrukh
    Alhayli, Saud
    Ahmed, Shad
    Mannan, Abdul
    Saleh, Mostafa
    Abdrabou, Ahmed
    Alsaadi, Husam
    Bin Salman, Ahmed
    Alfadhil, Haroon
    Hassanein, Mona
    Al Sagheir, Ahmed
    Morris, Tom
    Alhuraiji, Ahmad
    Fahad, Almohareb
    Aljurf, Mahmoud
    Ahmed, Syed Osman
    BLOOD, 2018, 132
  • [42] Temsirolimus (T) in patients (pts) with solid tumors with PTEN mutation (mut): results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
    Wentzel, Kristopher
    Rothe, Michael
    Mangat, Pam K.
    Garrett-Mayer, Elizabeth
    Ding, Li
    Pisick, Evan
    Krishnan, Mridula
    Behl, Deepti
    Alese, Olatunji B.
    Calfa, Carmen J.
    Cooper, Kathrine A.
    Duvivier, Herbert L.
    Induru, Raghava Reddy
    Ruzich, Janet C.
    Zhao, Song
    Grantham, Gina N.
    Gregory, Abigail
    Halabi, Susan
    Schilsky, Richard L.
    CANCER RESEARCH, 2023, 83 (08)
  • [43] Temsirolimus (T) in patients (pts) with solid tumors with mTOR mutation: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
    Srkalovic, Gordan
    Rothe, Michael
    Mangat, Pam K.
    Garrett-Mayer, Elizabeth
    Nazemzadeh, Reza
    Cannon, Timothy Lewis
    Duvivier, Herbert Leon
    Yost, Kathleen J.
    Pakkala, Suchita
    Alva, Ajjai Shivaram
    Behl, Deepti
    Gold, Philip Jordan
    Calfa, Carmen Julia
    Ngirailemesang, Melissa
    Powell, Steven Francis
    O'Lone, Raegan
    Grantham, Gina N.
    Halabi, Susan
    Schilsky, Richard L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] The prevalence of germline mutations among patients with solid tumors with genomic alterations identified on tumor testing: Results from a tertiary care academic center molecular tumor board.
    Watson, Catherine
    Tait, Sarah
    Soo, Lindsay
    Plichta, Jennifer Kay
    Zhang, Tian
    Castellar, Edgardo
    Armstrong, Andrew J.
    Previs, Rebecca A.
    Strickler, John H.
    Green, Michelle
    Datto, Michael
    Marcom, Paul Kelly
    Menendez, Carolyn S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] FACTORS INFLUENCING UPTAKE OF INDIVIDUALISED PRECISION MEDICINE TREATMENT RECOMMENDATIONS FOR HIGH-RISK PAEDIATRIC ONCOLOGY PATIENTS: RESULTS FROM THE PRISM ENGAGEMENT WITH CLINICIANS (PRE-CLIN) STUDY
    Senapati, Akanksha
    Mateos, Marion
    Kate, Hetherington
    Ziegler, David
    Lau, Loretta
    Wakefield, Claire
    Marshall, Glenn
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [46] Changes in the Immunogenetic Landscape with the Age of Disease Onset in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria: An Analysis of a Cohort of Adult and Pediatric Patients from the French National Reference Center for Aplastic Anemia
    Allain, Vincent
    Villemonteix, Juliette
    Leblanc, Thierry
    Chevillon, Florian
    Fortier, Catherine
    Fahd, Mony
    Dalle, Jean-Hugues
    Socie, Gerard
    De latour, Regis Peffault
    Caillat-Zucman, Sophie
    De Fontbrune, Flore Sicre
    BLOOD, 2023, 142
  • [47] Targeted therapy for gastrointestinaI (GI) tumors based on molecular profiles: Early results from MyPathway, an open-label phase IIa basket study in patients with advanced solid tumors.
    Hurwitz, Herbert
    Hainsworth, John D.
    Swanton, Charles
    Perez, Edith A.
    Sweeney, Christopher
    Burris, Howard A.
    Spigel, David
    Meric-Bernstam, Funda
    Strickland, Donald K.
    Leon, Larry
    Brammer, Melissa
    Beattie, Mary Stanley
    Bose, Ron
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [48] Crizotinib (C) in patients (pts) with solid tumors with MET amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
    Mileham, Kathryn F.
    Rothe, Michael
    Mangat, Pam K.
    Garrett-Mayer, Elizabeth
    Duvivier, Herbert L.
    Calfa, Carmen J.
    Dul, Carrie L.
    Marr, Alissa S.
    Ahn, Eugene R.
    Behl, Deepti
    Hall, Michael J.
    Mehmi, Inderjit
    Gaba, Anu
    Leidner, Rom
    Zalupski, Mark M.
    Grantham, Gina N.
    Gregory, Abigail
    Halabi, Susan
    Schilsky, Richard L.
    CANCER RESEARCH, 2023, 83 (08)
  • [49] Antibiotic resistance and genomic characterization of Mycobacterium abscessus complex isolates from patients with pulmonary tuberculosis in Iran: A multi-center study (2010-2021)
    Hashemzadeh, Mohammad
    Dezfuli, Aram Asareh Zadegan
    Khosravi, Azardokht
    Khosravi, Nazanin Ahmad
    Saki, Morteza
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2024, 71 (01) : 82 - 88
  • [50] Olaparib (O) in patients (pts) with solid tumors with BRCA1/2 mutation (mut): Results from the targeted agent and profiling utilization registry (TAPUR) study
    Ahn, E.
    Rothe, M.
    Mangat, P. K.
    Garrett-Mayer, E.
    Al Baghdadi, T.
    Baron, A. D.
    Krauss, J. C.
    Balmanoukian, A. S.
    Bauman, J. R.
    Hameed, M. K.
    Mileham, K. F.
    Thota, R.
    Gold, P. J.
    Meric-Bernstam, F.
    Powell, S. F.
    Yang, E. S.
    O'Lone, R.
    Grantham, G. N.
    Halabi, S.
    Schilsky, R. L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S583 - S584
12345